CompletedNCT06065735
Paroxetine heart rhythm study in healthy adults
About this title
Read the official source — NCT06065735Medication studyAges 18–65United KingdomAnxiety
Understand this study
Who was this study for?
This study was for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: October 2, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 38
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United Kingdom
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06065735
- Official title
Show the full official title
An Open-Label, Single Arm, Dose Escalating Concentration-QT Study to Investigate the Cardiac Effects and Safety of Paroxetine in Healthy Adult Participants
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is GlaxoSmithKline.
Did this study involve medication?
Yes. The study involved medication, including Paroxetine.
Who was this study for?
This study was for healthy volunteers. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
